Corinne Jenkins
Stock Analyst at Goldman Sachs
(1.68)
# 3,464
Out of 5,138 analysts
60
Total ratings
43.18%
Success rate
-3.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Jenkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Buy | $24 → $33 | $23.81 | +38.60% | 7 | Dec 15, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $141 → $157 | $113.34 | +38.52% | 11 | Dec 12, 2025 | |
| IDYA IDEAYA Biosciences | Maintains: Neutral | $27 → $30 | $37.03 | -18.98% | 6 | Oct 21, 2025 | |
| GERN Geron | Reinstates: Sell | $1 | $1.35 | -25.93% | 4 | Jul 10, 2025 | |
| TGTX TG Therapeutics | Maintains: Neutral | $20 → $22 | $29.54 | -25.52% | 8 | Nov 5, 2024 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $6 → $15 | $10.36 | +44.79% | 2 | May 14, 2024 | |
| ALT Altimmune | Reinstates: Neutral | $13 | $4.18 | +211.00% | 3 | Jan 24, 2024 | |
| HRMY Harmony Biosciences Holdings | Maintains: Sell | $25 → $28 | $36.04 | -22.31% | 7 | Jan 9, 2024 | |
| BTAI BioXcel Therapeutics | Maintains: Neutral | $192 → $64 | $1.99 | +3,116.08% | 6 | Aug 15, 2023 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $216 → $184 | $34.73 | +429.80% | 2 | Mar 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $2.74 | +666.42% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $37.18 | -62.35% | 2 | Dec 20, 2022 |
Roivant Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $24 → $33
Current: $23.81
Upside: +38.60%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $141 → $157
Current: $113.34
Upside: +38.52%
IDEAYA Biosciences
Oct 21, 2025
Maintains: Neutral
Price Target: $27 → $30
Current: $37.03
Upside: -18.98%
Geron
Jul 10, 2025
Reinstates: Sell
Price Target: $1
Current: $1.35
Upside: -25.93%
TG Therapeutics
Nov 5, 2024
Maintains: Neutral
Price Target: $20 → $22
Current: $29.54
Upside: -25.52%
Fulcrum Therapeutics
May 14, 2024
Upgrades: Buy
Price Target: $6 → $15
Current: $10.36
Upside: +44.79%
Altimmune
Jan 24, 2024
Reinstates: Neutral
Price Target: $13
Current: $4.18
Upside: +211.00%
Harmony Biosciences Holdings
Jan 9, 2024
Maintains: Sell
Price Target: $25 → $28
Current: $36.04
Upside: -22.31%
BioXcel Therapeutics
Aug 15, 2023
Maintains: Neutral
Price Target: $192 → $64
Current: $1.99
Upside: +3,116.08%
RAPT Therapeutics
Mar 15, 2023
Maintains: Buy
Price Target: $216 → $184
Current: $34.73
Upside: +429.80%
Mar 7, 2023
Maintains: Buy
Price Target: $25 → $21
Current: $2.74
Upside: +666.42%
Dec 20, 2022
Maintains: Buy
Price Target: $9 → $14
Current: $37.18
Upside: -62.35%